What's in Santen Pharmaceutical Asia Pte. Ltd.'s pipeline?

Santen Pharmaceutical Asia Pte. Ltd. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Santen Pharmaceutical Asia Pte. Ltd.'s portfolio?

Top competitors by shared drug class: Santen Inc., Santen Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/santen-pharmaceutical-asia-pte-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Santen Pharmaceutical Asia Pte. Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Santen Pharmaceutical Asia Pte. Ltd. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Eybelis ophthalmic solution 0.002%	Eybelis ophthalmic solution 0.002%	marketed	Rho kinase (ROCK) inhibitor	ROCK1/ROCK2	Ophthalmology

Therapeutic area mix

Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Santen Inc. · 1 shared drug class
Santen Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Santen Pharmaceutical Asia Pte. Ltd.:

Cite this brief

Drug Landscape (2026). Santen Pharmaceutical Asia Pte. Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/santen-pharmaceutical-asia-pte-ltd. Accessed 2026-05-17.